Chromatin Degradation During Apoptosis
细胞凋亡过程中染色质降解
基本信息
- 批准号:8295703
- 负责人:
- 金额:$ 27.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimal ModelAnimalsApoptosisApoptoticAutoimmune DiseasesBiochemicalBiologicalBiological AssayBiological ProcessCaenorhabditis elegansCalciumCancer EtiologyCaspaseCell DeathCell Death Signaling ProcessCell NucleusCell physiologyCellsChromatinChromosomesCleaved cellComplexDNADNA BindingDNA Double Strand BreakDNA-Binding ProteinsDefectDeoxyribonucleasesDevelopmentEnzymesEventGenesGeneticHomeostasisHomologous GeneHumanHydroxyl RadicalMalignant NeoplasmsMediatingMitochondriaMolecularMolecular CloningMolecular GeneticsMutationPathway interactionsPeptide HydrolasesPhosphatidylserinesProcessPumpRNA BindingRNA InterferenceRegulationRibonucleasesRoleSignal PathwaySignal TransductionSmall RNASpecificityStructureTissuesWorkbasecaspase-3cell killingcell suicidecontrolled releasegenome wide association studyhuman DICER1 proteinhuman diseasein vitro Assayin vivoinsightinterestmutantnew therapeutic targetnovelnucleasepresenilinpreventubiquilin
项目摘要
DESCRIPTION (provided by applicant): Fragmentation of chromosomal DNA is a critical step in apoptosis that prevents a cell from transcribing and replicating its genes and thus facilitates the cell killing process. Defects in this process can cause various pathological conditions, including autoimmune disorders and cancer. We have identified ten apoptotic nucleases and several non-nuclease factors involved in regulating and executing apoptotic chromosome fragmentation in C. elegans. They act in a sequential and CED-3 caspase-dependent manner to promote stepwise fragmentation and degradation of chromosomes. The process is initiated by a novel CED-3-mediated conversion of the dicer ribonuclease (RNase) into a deoxyribonuclease (DNase), which makes the first cuts on chromosomes. In parallel, a mitochondrial nuclease CPS-6 and its activator WAH-1 are released from mitochondria and translocated to the nucleus, where they interact and cooperate with other cell death nucleases to turn the initial cuts by dicer
into double-strand DNA breaks, leading to fragmentation and degradation of chromosomes. In this proposed work, we will carry out molecular genetic, biochemical, cell biological, and structural analyses to understand these two critical events of apoptotic DNA degradation. In Aim 1, we will investigate the molecular and structural basis underlying CED-3-mediated conversion of the dicer RNase into a DNase. In Aim 2, we will dissect the new signaling pathway that controls cytosolic calcium increase and release of the mitochondrial apoptogeneic factors during apoptosis. In Aim 3, we will perform molecular genetic and functional characterization of two new genes, cps-13 and cps-14, that regulate and coordinate two key cell death execution events, chromosome fragmentation and phosphatidylserine (PS) externalization. These studies should reveal the novel mechanism that controls the specificity and function switch of the dicer nuclease and new signaling mechanisms and players that control the release of the mitochondrial apoptogenic factors.
PUBLIC HEALTH RELEVANCE: Fragmentation of chromosomal DNA is a critical step in apoptosis, a cell suicide process that could go awry to cause multiple human diseases. Defects in apoptotic chromosome fragmentation can cause various pathological conditions, including autoimmune disorders and cancer. C. elegans is an excellent animal model for studying basic mechanisms of apoptosis and apoptotic chromosome fragmentation. This proposal seeks to understand the mechanisms that regulate activation of apoptotic nucleases and release of apoptosis factors from mitochondria through important signaling pathways. The studies may identify new genes, pathways, and mechanisms that regulate and execute apoptosis, leading to identification of new therapeutic targets or ideas to treat human disease such as Alzheimer's disease, autoimmune disorders, and cancer that are caused by abnormal apoptosis or DNA degradation.
描述(由申请人提供):染色体 DNA 的断裂是细胞凋亡的关键步骤,它阻止细胞转录和复制其基因,从而促进细胞杀伤过程。这一过程的缺陷可能导致各种病理状况,包括自身免疫性疾病和癌症。我们已经鉴定了秀丽隐杆线虫中参与调节和执行凋亡染色体断裂的十种凋亡核酸酶和几种非核酸酶因子。它们以顺序且依赖 CED-3 caspase 的方式发挥作用,促进染色体逐步断裂和降解。该过程由新型 CED-3 介导的切丁核糖核酸酶 (RNase) 转化为脱氧核糖核酸酶 (DNase) 启动,这在染色体上进行了第一次切割。与此同时,线粒体核酸酶 CPS-6 及其激活剂 WAH-1 从线粒体中释放出来并转移到细胞核,在那里它们与其他细胞死亡核酸酶相互作用并配合,以转变切丁机的初始切割
导致双链 DNA 断裂,导致染色体断裂和降解。在这项拟议的工作中,我们将进行分子遗传学、生化、细胞生物学和结构分析,以了解细胞凋亡 DNA 降解的这两个关键事件。在目标 1 中,我们将研究 CED-3 介导的切丁机 RNase 转化为 DNase 的分子和结构基础。在目标 2 中,我们将剖析细胞凋亡过程中控制胞浆钙增加和线粒体凋亡因子释放的新信号通路。在目标 3 中,我们将对两个新基因 cps-13 和 cps-14 进行分子遗传学和功能表征,这两个基因调节和协调两个关键的细胞死亡执行事件:染色体断裂和磷脂酰丝氨酸 (PS) 外化。这些研究应该揭示控制切丁核酸酶特异性和功能转换的新机制以及控制线粒体凋亡因子释放的新信号机制和参与者。
公共卫生相关性:染色体 DNA 碎片是细胞凋亡的关键步骤,细胞凋亡是一种细胞自杀过程,如果出错,可能会导致多种人类疾病。凋亡染色体断裂的缺陷可导致各种病理状况,包括自身免疫性疾病和癌症。线虫是研究细胞凋亡和细胞凋亡染色体断裂基本机制的优秀动物模型。该提案旨在了解通过重要信号通路调节凋亡核酸酶激活和线粒体释放凋亡因子的机制。这些研究可能会发现调节和执行细胞凋亡的新基因、途径和机制,从而确定新的治疗靶点或想法来治疗人类疾病,如阿尔茨海默病、自身免疫性疾病和由异常细胞凋亡或 DNA 降解引起的癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DING XUE其他文献
DING XUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DING XUE', 18)}}的其他基金
Fundamental mechanisms of apoptosis and phospholipid asymmetry
细胞凋亡和磷脂不对称的基本机制
- 批准号:
9071837 - 财政年份:2016
- 资助金额:
$ 27.21万 - 项目类别:
Fundamental mechanisms of apoptosis and phospholipid asymmetry
细胞凋亡和磷脂不对称的基本机制
- 批准号:
10084175 - 财政年份:2016
- 资助金额:
$ 27.21万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10631083 - 财政年份:2016
- 资助金额:
$ 27.21万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10582377 - 财政年份:2016
- 资助金额:
$ 27.21万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10413845 - 财政年份:2016
- 资助金额:
$ 27.21万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10799384 - 财政年份:2016
- 资助金额:
$ 27.21万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial elimination and radiation-induced bystander effects
父系线粒体消除和辐射引起的旁观者效应的基本机制
- 批准号:
10175605 - 财政年份:2016
- 资助金额:
$ 27.21万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 27.21万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 27.21万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 27.21万 - 项目类别: